Navigation Links
Rare Disease Therapeutics, Inc. Selects Accredo Health Group to Distribute Anascorp® for the Treatment of Centruroides Scorpion Sting Envenomation
Date:9/13/2011

FRANKLIN LAKES, N.J. and MEMPHIS, Tenn., Sept. 13, 2011 /PRNewswire/ -- Rare Disease Therapeutics, Inc. (RDT) announced today that its recently approved Anascorp® (Centruroides (Scorpion) Immune F(ab')2 (Equine) Injection) is now available on the market through Accredo Health Group, Inc. – a wholly owned subsidiary of Medco Health Solutions, Inc. (NYSE: MHS).  On August 3, 2011, Anascorp became the first treatment approved by the United States Food and Drug Administration (FDA) for Centruroides scorpion sting envenomation, and has been awarded orphan drug designation by the FDA, providing a seven-year period of market exclusivity.  Accredo is the sole U.S. specialty distributor of the medication.

(Logo:  http://photos.prnewswire.com/prnh/20100609/MEDCOLOGO)

"Accredo's experience successfully managing the nuances associated with products targeting rare diseases for small patient populations makes pharmaceutical manufacturers, such as Rare Disease Therapeutics, Inc., confident in trusting their product launch to our team," said Accredo President, Frank Sheehy.  "We look forward to working with Rare Disease Therapeutics, Inc. to deliver this important medication to those in need."

Accredo will offer specialty wholesale distribution services of Anascorp to hospitals and other appropriately licensed facilities.

"Rare Disease Therapeutics, Inc. has worked with Accredo for nearly ten years to provide patients with access to our potential life-saving medications for rare diseases," said Rare Disease Therapeutics, Inc. President Milton H. Ellis. "We worked successfully with Accredo to distribute Anascorp during the clinical trial phase, and we are excited to expand our relationship now that Anascorp is available commercially."

To obtain more information call 1-866-830-7437.

About Anascorp®

<
'/>"/>

SOURCE Medco Health Solutions, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. HemaQuest Pharmaceuticals Completes Patient Enrollment in Phase 2 Clinical Study of HQK-1001 in Patients With Sickle Cell Disease
2. Curemark Issued Patent for the Diagnosis of Parkinsons Disease
3. Regulus Therapeutics to Present New Advancements in microRNA Therapeutics for Treatment of Metabolic Diseases and Cancer
4. Anadys Setrobuvir Named One of Windhovers Top 10 Most Interesting Infectious Disease Projects to Watch
5. Galenea and CHDI Foundation Announce Collaboration to Identify Key Synaptic Dysfunction in Huntingtons Disease
6. Californians Recognized For Role In Helping Rare Disease Patients Who Need Lifesaving Therapies
7. Floridians Recognized for Role in Helping Rare Disease Patients Who Need Lifesaving Therapies
8. Californians and Floridians Recognized for Role in Helping Rare Disease Patients Who Need Lifesaving Therapies
9. Better Funding for Research into Blood Diseases Will Save More Lives
10. Alzheimers Drug Discovery Foundation Supports Madera Biosciences with a Grant to Advance Novel Drug Candidates for Alzheimers Disease
11. IRS Proposed Regulations on Orphan Drug Exclusion from Drug Tax Stand to Harm Future Development of Treatments for Rare Disease Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... LA JOLLA, Calif., Aug. 4, 2015   ... a biopharmaceutical company leading the discovery and development ... results and highlights for the quarter ended June ... corporate highlights.  "The second quarter ... time of progression for Regulus," said Paul Grint, ...
(Date:8/4/2015)... -- Dr. Keesha Ewers of The Functional ... flibanserin, or what is being touted as "pink ... female sexual desire back several decades. Diminished libido ... libido as a singular symptom with a singular ... Photo - http://photos.prnewswire.com/prnh/20150804/254705 ...
(Date:8/4/2015)... Calif., Aug. 4, 2015  Isis Pharmaceuticals, Inc. (Nasdaq: ... million and $18.9 million for the three and six ... net loss of $12.1 million and $43.4 million for ... results were driven primarily by the more than $90 ... related to the upfront payment from Bayer to license  ...
Breaking Medicine Technology:Regulus Reports Second Quarter 2015 Financial Results and Recent Highlights 2Regulus Reports Second Quarter 2015 Financial Results and Recent Highlights 3Regulus Reports Second Quarter 2015 Financial Results and Recent Highlights 4Regulus Reports Second Quarter 2015 Financial Results and Recent Highlights 5Regulus Reports Second Quarter 2015 Financial Results and Recent Highlights 6Regulus Reports Second Quarter 2015 Financial Results and Recent Highlights 7Regulus Reports Second Quarter 2015 Financial Results and Recent Highlights 8Regulus Reports Second Quarter 2015 Financial Results and Recent Highlights 9Regulus Reports Second Quarter 2015 Financial Results and Recent Highlights 10Potential FDA Approval of "Pink Viagra" Sends Wrong Message 2Potential FDA Approval of "Pink Viagra" Sends Wrong Message 3Potential FDA Approval of "Pink Viagra" Sends Wrong Message 4Potential FDA Approval of "Pink Viagra" Sends Wrong Message 5Isis Reports Financial Results And Highlights For Second Quarter 2015 2Isis Reports Financial Results And Highlights For Second Quarter 2015 3Isis Reports Financial Results And Highlights For Second Quarter 2015 4Isis Reports Financial Results And Highlights For Second Quarter 2015 5Isis Reports Financial Results And Highlights For Second Quarter 2015 6Isis Reports Financial Results And Highlights For Second Quarter 2015 7Isis Reports Financial Results And Highlights For Second Quarter 2015 8Isis Reports Financial Results And Highlights For Second Quarter 2015 9Isis Reports Financial Results And Highlights For Second Quarter 2015 10Isis Reports Financial Results And Highlights For Second Quarter 2015 11Isis Reports Financial Results And Highlights For Second Quarter 2015 12Isis Reports Financial Results And Highlights For Second Quarter 2015 13Isis Reports Financial Results And Highlights For Second Quarter 2015 14Isis Reports Financial Results And Highlights For Second Quarter 2015 15Isis Reports Financial Results And Highlights For Second Quarter 2015 16
(Date:8/4/2015)... ... August 04, 2015 , ... assistPoint Partners, LLC ... to consolidate oncology patient assistance programs. Through a secure web portal, assistPoint connects ... is an enterprise level, cloud-based application and workflow solution. This provides cancer center ...
(Date:8/4/2015)... D.C. (PRWEB) , ... August 04, 2015 , ... ... fellowship focused on sexual and reproductive health and rights in Indonesia for a ... will visit a number of sites in Indonesia and attend the International Conference ...
(Date:8/4/2015)... Raton, FL (PRWEB) , ... August 04, 2015 ... ... diagnostic testing organization which provides vascular, electrocardiogram (EKG), echocardiogram, and NCV testing, announced ... but has been successfully identifying previously undiagnosed cardiovascular abnormalities one program at a ...
(Date:8/4/2015)... ... August 04, 2015 , ... An article published July ... be a viable method for encouraging people to lose weight. Specifically the study compared ... their weight loss success, adding a financial incentive to the overall incentive of increased ...
(Date:8/4/2015)... ... August 04, 2015 , ... Bayco Products, Inc. announces a new industrial-grade ... example, on hard hats that have a flip-up face shield. The sleek contours of ... work without having to remove their headlamp when raising or lowering their face shield ...
Breaking Medicine News(10 mins):Health News:assistPoint.com Web Site Launched 2Health News:UN Foundation Announces Press Fellowship to Indonesia with Focus on Women’s Health and Rights 2Health News:Colleges and High Schools Across the Country Are Joining the Wimbledon U Team Uncovering Unknown Cardiac Conditions and Promoting Heart Healthy Athletes 2Health News:Colleges and High Schools Across the Country Are Joining the Wimbledon U Team Uncovering Unknown Cardiac Conditions and Promoting Heart Healthy Athletes 3Health News:Article on Incentivizing Weight Loss Mirrors Similar Motivations Surrounding Weight Loss Surgery, Says Dr. Feiz & Associates 2Health News:New Nightstick® NSP-4614B Dual-LightTM Headlamp fits more functionality into more places 2Health News:New Nightstick® NSP-4614B Dual-LightTM Headlamp fits more functionality into more places 3
... Food and Drug Administration takes days to track down the ... optimizing a sensor that can enable growers to do the ... of chemical engineering at Drexel University, has developed an “intelligent” ... a few dollars, the sensor can provide a result within ...
... For a long time, most healthy adults have had ... pneumonia, and the tetanus-diphtheria (Td) booster.// But now two ... 2006 issue of Harvard Men’s Health Watch. ,Shingles ... virus, the same virus responsible for chickenpox. In most ...
... National Dairy Development Board (NDDB), is like the proverbial ... out its batch of DNA Hepatitis –B Vaccine//, which ... to the other brands in the market. ... its facility in Gachibowli, will be sold under the ...
... may be a potential treatment for blindness in the elderly ... Cell Technology, Massachusetts, and Raymond Lund and colleagues at the ... ,In this study, embryonic stem cells that have ... of cell present in the body were used to enhance ...
... are in constant fear of getting allergic to them. Now ... do not cause any allergies are on sale for a ... in the saliva and urine triggers off allergic reactions to ... California-based biotech firm Allerca conducted tests on thousands of cats ...
... of the prostate could be life threatening. September has been ... skin cancer// prostrate cancer has been found to be the ... country with one out of every three men diagnosed with ... ,Prostate health is especially important for African-American men with death ...
Cached Medicine News:
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: